» Articles » PMID: 27525055

Gestational Diabetes Mellitus: Screening with Fasting Plasma Glucose

Overview
Specialty Endocrinology
Date 2016 Aug 16
PMID 27525055
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Fasting plasma glucose (FPG) as a screening test for gestational diabetes mellitus (GDM) has had a checkered history. During the last three decades, a few initial anecdotal reports have given way to the recent well-conducted studies. This review: (1) traces the history; (2) weighs the advantages and disadvantages; (3) addresses the significance in early pregnancy; (4) underscores the benefits after delivery; and (5) emphasizes the cost savings of using the FPG in the screening of GDM. It also highlights the utility of fasting capillary glucose and stresses the value of the FPG in circumventing the cumbersome oral glucose tolerance test. An understanding of all the caveats is crucial to be able to use the FPG for investigating glucose intolerance in pregnancy. Thus, all health professionals can use the patient-friendly FPG to simplify the onerous algorithms available for the screening and diagnosis of GDM - thereby helping each and every pregnant woman.

Citing Articles

Risk factors and diagnostic performance of predictors as a screening technique for gestational diabetes mellitus: a retrospective cross-sectional study.

Khobrani F, Alzahrani A, Binmahfoodh D, Hemedy R, Abbas S Ann Med Surg (Lond). 2024; 86(8):4384-4388.

PMID: 39118718 PMC: 11305797. DOI: 10.1097/MS9.0000000000002247.


A Critical Review of Diagnostic Strategies and Maternal Offspring Complications in Gestational Diabetes Mellitus.

Thakur A, Agrawal S, Chakole S, Wandile B Cureus. 2024; 15(12):e51016.

PMID: 38264369 PMC: 10804211. DOI: 10.7759/cureus.51016.


Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review.

Sun X, McKeaveney C, Noble H, OHara H, Perra O J Diabetes Investig. 2023; 15(4):500-516.

PMID: 38102930 PMC: 10981150. DOI: 10.1111/jdi.14128.


Employing fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studies.

Rai A, Sletner L, Jenum A, Overby N, Stafne S, Qvigstad E Front Endocrinol (Lausanne). 2023; 14:1278523.

PMID: 38098869 PMC: 10720624. DOI: 10.3389/fendo.2023.1278523.


Response to "Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus".

Llerena-Velastegui J, Guevara-Espinoza S, Villacis-Lopez C, Santafe-Abril G Acta Diabetol. 2023; 60(6):857-858.

PMID: 36914779 DOI: 10.1007/s00592-023-02067-2.


References
1.
Juutinen J, Hartikainen A, Bloigu R, Tapanainen J . A retrospective study on 435 women with gestational diabetes: fasting plasma glucose is not sensitive enough for screening but predicts a need for insulin treatment. Diabetes Care. 2000; 23(12):1858-9. DOI: 10.2337/diacare.23.12.1858. View

2.
Virally M, Laloi-Michelin M . Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy. Diabetes Metab. 2010; 36(6 Pt 2):549-65. DOI: 10.1016/j.diabet.2010.11.008. View

3.
Rey E, Hudon L, Michon N, Boucher P, Ethier J, Saint-Louis P . Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness. Clin Biochem. 2004; 37(9):780-4. DOI: 10.1016/j.clinbiochem.2004.05.018. View

4.
Agarwal M, Dhatt G, Safraou M . Gestational diabetes: using a portable glucometer to simplify the approach to screening. Gynecol Obstet Invest. 2008; 66(3):178-83. DOI: 10.1159/000140602. View

5.
Reichelt A, Spichler E, Branchtein L, Nucci L, Franco L, Schmidt M . Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working Group. Diabetes Care. 1998; 21(8):1246-9. DOI: 10.2337/diacare.21.8.1246. View